Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4393926 | 4163963 | F | 1 | 4393926-9 | 20020101 | 20040621 | 20040702 | EXP | SUSI-2004-00361 | SHIRE PHARMACEUTICALS DEVELOPMENT INC. | 9 | YR | M | N | 20040630 | MD |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4393926 | 1005001146 | PS | ADDERALL XR 10 | 1 | 20 MG, 1X/DAY: QD | D | D | 21303 | |||
| 4393926 | 1005017873 | SS | ADDERALL 10 | 1 | D | D |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 4393926 | 1005001146 | ATTENTION DEFICIT/HYPERACTIVITY DISORDER |
| 4393926 | 1005017873 | ATTENTION DEFICIT/HYPERACTIVITY DISORDER |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 4393926 | DS |
| 4393926 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 4393926 | BLINDNESS |
| 4393926 | DEAFNESS BILATERAL |
| 4393926 | EYE HAEMORRHAGE |
| 4393926 | GLAUCOMA |
| 4393926 | RETINAL HAEMORRHAGE |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 4393926 | HP |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 4393926 | 1005001146 | 20020801 | |||
| 4393926 | 1005017873 | 19980101 | 20020801 |